Clinical Trials Directory

Trials / Completed

CompletedNCT01260987

Fractional CO2 Laser Assisted Photodynamic Therapy

Conventional Versus Fractional CO2 Laser Assisted Photodynamic Therapy for Basal Call Carcinomas and Actinic Keratoses

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
47 (actual)
Sponsor
Bispebjerg Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Nodular Basal Cell Carcinomas: Compare the efficacy and safety of conventional versus fractional laser assisted PDT for difficult to treat nodular cell carcinomas in the face. Actinic keratosis: Compare the efficacy and safety of conventional versus fractional laser assisted PDT for moderate to severe actinic keratoses located in the face and on the hands.

Conditions

Interventions

TypeNameDescription
DRUGConventional photodynamic therapyPhotodynamic therapy using methyl-aminolevulinate and red light (37 J/cm2)
DRUGFractional CO2 laser assisted PDTPretreatment with fractional CO2 laser before methyl-aminolevulinate PDT

Timeline

Start date
2010-10-01
Primary completion
2012-08-01
Completion
2012-08-01
First posted
2010-12-16
Last updated
2015-07-30

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01260987. Inclusion in this directory is not an endorsement.